Axsome Therapeutics (AXSM) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026)
Axsome Therapeutics (AXSM) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Axsome Therapeutics |
13.07 Bn |
12.76 Bn |
176.48 Mn |
-6.92% |
| Date | Value |
|---|
| Mar 31, 2026 |
-6.92% |
| Dec 31, 2025 |
-8.01% |
| Sep 30, 2025 |
-1.18% |
| Jun 30, 2025 |
1.67% |
| Mar 31, 2025 |
18.81% |
| Dec 31, 2024 |
27.19% |
| Sep 30, 2024 |
29.45% |
| Jun 30, 2024 |
105.49% |
| Mar 31, 2024 |
121.90% |
| Dec 31, 2023 |
152.35% |
| Sep 30, 2023 |
190.17% |
| Jun 30, 2023 |
189.22% |
| Mar 31, 2023 |
173.09% |
| Dec 31, 2022 |
186.75% |
| Sep 30, 2022 |
162.78% |
| Jun 30, 2022 |
149.73% |
| Mar 31, 2022 |
125.14% |
| Dec 31, 2021 |
76.26% |
| Sep 30, 2021 |
70.05% |
| Jun 30, 2021 |
6.73% |
